GeneDx Holdings (WGS) Minority Interest (2020 - 2021)

GeneDx Holdings (WGS) posted quarterly Minority Interest of $294.7 million for Q1 2021, down 16.55% sequentially from $353.2 million in Q4 2020.

GeneDx Holdings (WGS) Minority Interest (2020 - 2021) Analysis & Trends

GeneDx Holdings has disclosed Minority Interest across 2 years of filings, most recently posting $294.7 million for Q1 2021.

  • In Q1 2021, Minority Interest changed N/A year-over-year to $294.7 million; the TTM figure through Mar 2021 stood at $294.7 million (changed N/A YoY), while the FY2020 annual figure was $353.2 million, changed N/A from the prior year.
  • Minority Interest retreated to $294.7 million in Q1 2021, from $353.2 million in the prior quarter.
  • Over the last five years, Minority Interest for WGS reached as high as $353.2 million in Q4 2020 and fell as low as $294.7 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 GeneDx Holdings 2.10 Bn 1.93 Bn 68.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2021 294.75 Mn
Dec 31, 2020 353.22 Mn